ADAG CIK: 1818838

Adagene Inc.

  • China
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.4
FY22:
−48.6
FY23:
−28.5
FY24:
−29.7
FY25:
−15.7
Change from FY21 to FY25
millions USD
FY21:
−2.51
FY22:
−0.69
FY23:
−0.08
FY24:
1.11
FY25:
0.48
Change from FY21 to FY25
millions USD
FY21:
145
FY22:
17.8
FY23:
−5.37
FY24:
3.77
FY25:
4.45
millions USD
FY21:
99.2
FY22:
−30.6
FY23:
−33.8
FY24:
−24.7
FY25:
−10.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.9
FY22:
−49.3
FY23:
−28.5
FY24:
−29.7
FY25:
−15.7

All amounts in millions USD Data source:SEC EDGAR